💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Enanta Pharmaceuticals, Inc. (ENTA)
« Back to company indexENTA Chatter Timeline
Stock Ticker for ENTA
Most Active Tweeters for ENTA
| User | Tweets |
|---|---|
| @ShortAlgoKing | 8 |
| @TortozaLeandro | 7 |
| @DewDiligence | 6 |
| @MaiteMerenda | 4 |
| @FlashAlert_me | 4 |
Recent Tweets for ENTA
 |
@ExecPayOrg Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M https://t.co/oQe0E22OCR $ENTA #execpay January 25th 2022, 10:01pm |
 |
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/E4Xl4YEDk3 January 25th 2022, 7:01pm |
 |
@DewDiligence @AdamB1438 Correction: I bought $ENTA at $17 and change in *2013*: https://t.co/RP6yKUICQI January 25th 2022, 6:01pm |
|
@DewDiligence $ENTA's insiders cumulatively own a 12.4% equity stake: https://t.co/H89qfO4O6m January 25th 2022, 6:01pm |
 |
@VatqLu $ENTA Waiting for Buy signal , https://t.co/AFcehWxOB3 January 25th 2022, 2:01pm |
 |
@sentivcapital RT @DewDiligence: $PRDS phase-1a is investigating ritonavir boosting: https://t.co/FhPCuBUDUN (I’m long $ENTA.) January 24th 2022, 8:01pm |
|
@DewDiligence $PRDS phase-1a is investigating ritonavir boosting: https://t.co/FhPCuBUDUN (I’m long $ENTA.) January 24th 2022, 8:01pm |
 |
@A1Syad $ENTA Waiting for Buy signal. Chart by https://t.co/1MjnDHV7ua https://t.co/a7Sjc7CGhM January 24th 2022, 5:01pm |
 |
@ShortAlgoKing $ENTA Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/uumwTyS4eX January 24th 2022, 5:01pm |
|
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/1Yyb2ciVNk January 24th 2022, 3:01pm |
 |
@MaiteMerenda $ENTA Awaiting Buy Signal. Chart by https://t.co/t5kOjgsWN3 https://t.co/OTQJIxXVrs January 24th 2022, 11:01am |
|
@ShortAlgoKing $ENTA Watching for Buy Signal. Chart by https://t.co/qchl9O5K2n https://t.co/1oEk6KoNue January 23rd 2022, 12:01pm |
 |
@newsfilterio Form DEF 14A (other definitive proxy statements) filed with the SEC $ENTA https://t.co/w11t2GnwAx January 22nd 2022, 12:01am |
|
@newsfilterio Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $ENTA https://t.co/ia4jha5t9s January 22nd 2022, 12:01am |
 |
@FlashAlert_me $ENTA [15s. delayed] filed form DEFA14A on January 21, 16:03:43 https://t.co/qMNqPqcIds January 21st 2022, 9:01pm |
|
@FlashAlert_me $ENTA [15s. delayed] filed form DEF 14A on January 21, 16:01:51 https://t.co/B8eXdsbcZ8 January 21st 2022, 9:01pm |
|
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/wfMB7xrN1t January 21st 2022, 8:01pm |
|
@MaiteMerenda $ENTA Bullish pattern building. Chart by https://t.co/t5kOjgsWN3 https://t.co/EKWzUppnqD January 21st 2022, 6:01pm |
|
@ShortAlgoKing $ENTA Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/uUS7AGbt2c January 21st 2022, 2:01pm |
|
@MaiteMerenda $ENTA Bullish pattern forming. Chart by https://t.co/t5kOjgsWN3 https://t.co/97Tegk12zc January 20th 2022, 6:01pm |
|
@ShortAlgoKing $ENTA Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/0hmejd0VMJ January 20th 2022, 2:01pm |
|
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/SRN9Cdocj9 January 19th 2022, 8:01pm |
|
@ShortAlgoKing $ENTA Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/JWCF7QYj1n January 19th 2022, 12:01pm |
 |
@StckPro $ENTA NEW ARTICLE : JMP Securities Reiterates Their Buy Rating on Enanta Pharmaceuticals (ENTA)… https://t.co/w1WOnZ7AyI January 19th 2022, 5:01am |
|
@DewDiligence My money is on $ENTA, of course, although I picked $PRDS for a small position in the 2022 Silicon Investor Charity… https://t.co/COPSdls24c January 18th 2022, 7:01pm |
|
@DewDiligence WSJ piece on $PRDS COVID antiviral gets the list of competitors right, i.e. $ENTA and Shionogi:… https://t.co/IuyqfdC9Y7 January 18th 2022, 7:01pm |
|
@DewDiligence $ENTA CEO exercised AND HELD $600K of stock on 1/15/21: https://t.co/s0v6QEgdgU Exercising AND HOLDING—paying the… https://t.co/gnK2kvnMwh January 18th 2022, 1:01pm |
|
@ShortAlgoKing $ENTA Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/Q6R91JoVKo January 18th 2022, 12:01pm |
|
@FlashAlert_me $ENTA [15s. delayed] filed SEC form 4: President and CEO Luly Jay R.: Converted securities 10,063 of Common Stock… https://t.co/Z4hTiQd0TM January 18th 2022, 11:01am |
 |
@quantisnow $ENTA ? SEC Form 4: Luly Jay R. exercised 10,063 shares at a strike of $11.77, increasing direct ownership by 1% to… https://t.co/pyvdVsF6Q0 January 18th 2022, 11:01am |
 |
@MarcJacksonLA $ENTA Enanta Pharmaceuticals Receives Consensus Rating of "Hold" from Brokerages | $90.25 Average PT… https://t.co/G52ADvFHB6 January 16th 2022, 2:01pm |
 |
@ShogunTrade $ENTA Awaiting Buy Signal. Free 7 Day Trial at https://t.co/6vnULU2sSf https://t.co/iZwRrbyU5k January 15th 2022, 8:01pm |
|
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/yliiHIHqbk January 15th 2022, 6:01pm |
|
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/WvQQ61prcu January 14th 2022, 6:01pm |
 |
@bkfViking123 RT @bkfViking123: $enta 200 day https://t.co/JkO0UhBvez January 14th 2022, 4:01pm |
 |
@SismasStock $ENTA waiting for Buy signal on ENTA with https://t.co/WNHrn3Pr7t https://t.co/trtiw3LZgl January 14th 2022, 2:01pm |
 |
@shortablestocks $ENTA is short sale restricted for 2022-01-14. https://t.co/eD1RkJadMh January 14th 2022, 2:01pm |
|
@A1Syad $ENTA Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/oHMQfdsZT0 January 14th 2022, 1:01pm |
|
@ShortAlgoKing I just posted "Monitoring for a buy entry on $ENTA with UltraAlgo." on Reddit https://t.co/XcsW5p4wOx January 14th 2022, 12:01pm |
|
@bkfViking123 $enta 200 day https://t.co/JkO0UhBvez January 14th 2022, 6:01am |
 |
@alerts_real $ENTA Real price will come out soon; Follow price targets https://t.co/6YesXV6dRW January 14th 2022, 6:01am |
 |
@InsiderAlerts4U $ENTA: New Insider Filing on ENANTA PHARMACEUTICALS INC's Sr. VP & Chief Medical Officer NATHALIE ADDA: https://t.co/vyXmjs5jJ1 January 14th 2022, 1:01am |
 |
@day_trading_de ENTA (ENANTA PHARMACEUTICALS INC) ? #Insider #stock alert! ? #Sale on 2022-01-11 - $ENTA ??: Adda Nathalie (Sr. VP… https://t.co/Ty6tdlOwKx January 14th 2022, 1:01am |
|
@FlashAlert_me $ENTA [15s. delayed] filed SEC form 4: Sr. VP & Chief Medical Officer Adda Nathalie: Disposed 12,536 of Common Sto… https://t.co/gmXib2rfYx January 14th 2022, 12:01am |
 |
@Ba4Saso $ENTA Almost ripe for a jump! Chart by https://t.co/z6vAd7dl0q https://t.co/8ZXsuIrlil January 13th 2022, 9:01pm |
 |
@mehabecapital $ENTA @ 64.77 (-6.52%) : On the hour https://t.co/DhzsKD57Fv January 13th 2022, 7:01pm |
|
@mehabecapital $ENTA @ 64.50 (-7.19%) : Enanta under pressure after SVB Leerink slashed price target https://t.co/aTkqtZT58P January 13th 2022, 6:01pm |
|
@TortozaLeandro $ENTA Awaiting for Buy signal on ENTA with https://t.co/BVorhZSlcz https://t.co/cta54HkX3p January 13th 2022, 5:01pm |
 |
@ChartMill $ENTA was analyzed by 16 analysts. The buy consensus is at 76%. So analysts seem to be mildly confident about $ ...… https://t.co/kwsFMe3k45 January 13th 2022, 4:01pm |
 |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 496 January 13th 2022, 2:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?